Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Dihydroisoperparine
2. Drotaverin
3. Drotaverine
4. Isodihydroperparine
5. No-shpa
6. No-spa
7. Nospan
8. Nospanum
1. 985-12-6
2. Drotaverine Hcl
3. Drotin; Isodihydroperparine Hydrochloride; Nosh-bra; No-spa
4. Dihydroisoperparine; Drotaverin; Isodihydroperparine; Perparine, Isodihydro-
5. 1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-3,4-dihydro-2h-isoquinoline;hydrochloride
6. Bcp32864
7. Akos030255224
8. Db-057733
9. Ft-0603535
10. Drotaverine Hcl;tetraspasmin-lefa; Ctk8f9383
11. 1-[(3,4-diethoxy Phenyl)methylene]-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline Hydrochloride
Molecular Weight | 434.0 g/mol |
---|---|
Molecular Formula | C24H32ClNO4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 9 |
Exact Mass | 433.2019862 g/mol |
Monoisotopic Mass | 433.2019862 g/mol |
Topological Polar Surface Area | 49 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 511 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 1 |
Covalently Bonded Unit Count | 2 |
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ANALYTICAL
ABOUT THIS PAGE
35
PharmaCompass offers a list of Drotaverine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Drotaverine manufacturer or Drotaverine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Drotaverine manufacturer or Drotaverine supplier.
PharmaCompass also assists you with knowing the Drotaverine API Price utilized in the formulation of products. Drotaverine API Price is not always fixed or binding as the Drotaverine Price is obtained through a variety of data sources. The Drotaverine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Drotaverine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Drotaverine Hydrochloride, including repackagers and relabelers. The FDA regulates Drotaverine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Drotaverine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Drotaverine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Drotaverine Hydrochloride supplier is an individual or a company that provides Drotaverine Hydrochloride active pharmaceutical ingredient (API) or Drotaverine Hydrochloride finished formulations upon request. The Drotaverine Hydrochloride suppliers may include Drotaverine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Drotaverine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Drotaverine Hydrochloride written confirmation (Drotaverine Hydrochloride WC) is an official document issued by a regulatory agency to a Drotaverine Hydrochloride manufacturer, verifying that the manufacturing facility of a Drotaverine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Drotaverine Hydrochloride APIs or Drotaverine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Drotaverine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Drotaverine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
Drotaverine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Drotaverine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Drotaverine Hydrochloride GMP manufacturer or Drotaverine Hydrochloride GMP API supplier for your needs.
A Drotaverine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Drotaverine Hydrochloride's compliance with Drotaverine Hydrochloride specifications and serves as a tool for batch-level quality control.
Drotaverine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Drotaverine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Drotaverine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Drotaverine Hydrochloride EP), Drotaverine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Drotaverine Hydrochloride USP).